Estimates Revisions TransMedics Group, Inc.
Stocks
TMDX
US89377M1099
Advanced Medical Equipment & Technology
|
Real-time Estimate
Cboe BZX
15:59:50 2026-08-20 EDT
|
5-day change | 1st Jan Change | ||
| 90.76 USD | -3.42% |
|
+2.24% | -24.66% |
| 08-05 | UBS Adjusts Price Target on TransMedics Group to $77 From $80, Maintains Neutral Rating | MT |
| 08-05 | TransMedics Group, Inc., Q2 2026 Earnings Call, Aug 04, 2026 |
Turnover - Evolution of Analysts' Estimates
Earnings Per Share (EPS) - Evolution of Analysts' Estimates
EBIT - Evolution of Analysts' Estimates
Dividend / Share (DPS) - Evolution of Analysts' Estimates
Cash or Net Debt - Evolution of Analysts' Estimates
| 1m. Revenue rev. | 1y. Revenue rev. | 1y. EPS revision | ||
|---|---|---|---|---|
 | ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| Average | ||||
| Weighted average by Cap. |
Turnover
Earnings Per Share (EPS)
EBIT
Dividend / Share (DPS)
Cash or Net Debt
- Stock Market
- Stocks
- TMDX Stock
- Consensus TransMedics Group, Inc.
- Estimates Revisions
Select your edition
All financial news and data tailored to specific country editions
